Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of The Efficacy And Safety of An Irreversible Electroporation (IRE) System For Treatment of Inferior Turbinate Hypertrophy With Nasal Obstruction

NCT06438185 is registered in ClinicalTrials.gov with ENTire Medical Ltd. as lead sponsor.

NCT NCT06438185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06438185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of The Efficacy And Safety of An Irreversible Electroporation (IRE) System For Treatment of Inferior Turbinate Hypertrophy With Nasal Obstruction
Lead sponsor
ENTire Medical Ltd.
Phase
Not applicable
Overall status
Completed
Start date
March 7, 2024
Completion date
June 27, 2025
Enrollment
48 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

inferior turbinate hypertrophy, nasal obstruction, turbinate; hypertrophy mucous membrane